These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24964806)

  • 21. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
    Reading PC; Symons JA; Smith GL
    J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity.
    Yuan H; You J; You H; Zheng C
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.
    Liu R; Moss B
    J Virol; 2018 May; 92(9):. PubMed ID: 29444943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection.
    Benfield CTO; Ren H; Lucas SJ; Bahsoun B; Smith GL
    J Gen Virol; 2013 Jul; 94(Pt 7):1647-1657. PubMed ID: 23580427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity.
    Fu X; Rivera A; Tao L; Zhang X
    Mol Ther; 2012 Oct; 20(10):1871-81. PubMed ID: 22692498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
    Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
    J Virol; 2019 May; 93(10):. PubMed ID: 30814284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein.
    Kasani SK; Cheng HY; Yeh KH; Chang SJ; Hsu PW; Tung SY; Liang CT; Chang W
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of the type I interferons alpha4, beta, and epsilon on antiviral activity and vaccine efficacy.
    Day SL; Ramshaw IA; Ramsay AJ; Ranasinghe C
    J Immunol; 2008 Jun; 180(11):7158-66. PubMed ID: 18490714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the viral interleukin 1beta receptor improves CD8+ T-cell memory responses elicited upon immunization with modified vaccinia virus Ankara.
    Staib C; Kisling S; Erfle V; Sutter G
    J Gen Virol; 2005 Jul; 86(Pt 7):1997-2006. PubMed ID: 15958679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling.
    Colamonici OR; Domanski P; Sweitzer SM; Larner A; Buller RM
    J Biol Chem; 1995 Jul; 270(27):15974-8. PubMed ID: 7608155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How Does Vaccinia Virus Interfere With Interferon?
    Smith GL; Talbot-Cooper C; Lu Y
    Adv Virus Res; 2018; 100():355-378. PubMed ID: 29551142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma.
    Liu G; Zhai Q; Schaffner DJ; Wu A; Yohannes A; Robinson TM; Maland M; Wells J; Voss TG; Bailey C; Alibek K
    FEMS Immunol Med Microbiol; 2004 Apr; 40(3):201-6. PubMed ID: 15039095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified vaccinia virus Ankara induces Toll-like receptor-independent type I interferon responses.
    Waibler Z; Anzaghe M; Ludwig H; Akira S; Weiss S; Sutter G; Kalinke U
    J Virol; 2007 Nov; 81(22):12102-10. PubMed ID: 17855554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.
    Myskiw C; Arsenio J; Hammett C; van Bruggen R; Deschambault Y; Beausoleil N; Babiuk S; Cao J
    J Virol; 2011 Dec; 85(23):12280-91. PubMed ID: 21917954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune modulation by proteins secreted from cells infected by vaccinia virus.
    Smith GL; Symons JA; Alcamí A
    Arch Virol Suppl; 1999; 15():111-29. PubMed ID: 10470273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. M135R is a novel cell surface virulence factor of myxoma virus.
    Barrett JW; Sypula J; Wang F; Alston LR; Shao Z; Gao X; Irvine TS; McFadden G
    J Virol; 2007 Jan; 81(1):106-14. PubMed ID: 17065210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of a non-canonical JAK-STAT pathway in IFN therapy of poxvirus infection and multiple sclerosis: An example of Occam's Broom?
    Ahmed CM; Johnson HM
    JAKSTAT; 2013 Oct; 2(4):e26227. PubMed ID: 24416655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL2 expression is mediated by type I IFN receptor and recruits NK and T cells to the lung during MVA infection.
    Lehmann MH; Torres-Domínguez LE; Price PJ; Brandmüller C; Kirschning CJ; Sutter G
    J Leukoc Biol; 2016 Jun; 99(6):1057-64. PubMed ID: 26992431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.